Contact this trialFirst, we need to learn more about you.
Cohort A, Arm II (nivolumab, relatlimab) for Bladder Cancer
Recruiting2 awardsPhase 3
Decatur, Illinois
This trial is testing a new blood test called Signatera to see if it can detect bladder cancer DNA in the blood. The test will be used to determine if patients who have had their bladder removed
Fill-in a few details and create your profileHaving a profile will help us send you recommended trials and speed up your application in the future.
We will keep your details privateWe won’t share unless you give us permission. By completing this form you agree to our privacy policy
Get in touch with the study teamWe’ll send your responses to the study team and help you to setup your first screening. This is not the start of informed consent. Screening happens between you and the trial.